2
Disclosures
Jan 13, 2026 — Mar 25, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 25 Equity Issuance D.Western Therapeutics Insti: Western Therapeutics Updates Development Plan for Glaucoma Treatment PDF
Mar 19 Other D.Western Therapeutics Insti: tute Completes Global Phase III Clinical Trial Observation Period for K-321 PDF

Disclosure Types

Equity Issuance: 1 Other: 1